In:
British Journal of Haematology, Wiley, Vol. 189, No. 4 ( 2020-05), p. 745-750
Kurzfassung:
Outcome of 333 children with acute myeloid leukaemia relapsing after a first allogeneic haematopoietic stem cell transplantation was analyzed. Four‐year probability of overall survival (4y‐pOS) was 14%. 4y‐pOS for 122 children receiving a second haematopoietic stem cell transplantation was 31% and 3% for those that did not ( P = 〈 0·0001). Achievement of a subsequent remission impacted survival ( P = 〈 0·0001). For patients receiving a second transplant survival with or without achieving a subsequent remission was comparable. Graft source (bone marrow vs. peripheral blood stem cells, P = 0·046) and donor choice (matched family vs. matched unrelated donor, P = 0·029) positively impacted survival after relapse. Disease recurrence and non‐relapse mortality at four years reached 45% and 22%.
Materialart:
Online-Ressource
ISSN:
0007-1048
,
1365-2141
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2020
ZDB Id:
1475751-5
Permalink